The Micro-engineering and Nano-technology Revolution

The Micro-engineering and Nano-technology Revolution

Market Analysis

The microtechnology market alone is set to grow by 186% from 2000–2005. The Micro-engineering and Nano-technology Revolution is a report that will allow you to exploit the new opportunities emerging in the market. It provides extensive detail of the growth, innovation and technology uptake of micro- and nano-technologies, allowing you to see where real investment opportunities lie.

This report examines how these technologies can be used in the following areas and how the conventional markets could be impacted on:

Materials
Implants
Tissue engineering
Drug delivery
Diagnostics
Cardiology
Pharmaceuticals
Disposable products

Pipeline technologies and technologies currently on the market are investigated and the companies heavily involved in developing these products are profiled.

This report will allow you to:

Assess the potential of the market
Discover which areas will see the largest growth in the next 5 years
Learn which areas are seeing the greatest investment
Find out what technology is about to enter the market

PRICE: £595/$1,250/¥143,000
PUBLISHED: DECEMBER 2000
PAGES: 150+
REF: CBS851E

For further information about this report, please contact our Customer Helpdesk on:
Tel: +44 (0)20 8332 8965 / 66
Fax: +44 (0)20 8332 8992
E-mail: [email protected]

TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
EXECUTIVE SUMMARY
ABBREVIATIONS

CHAPTER 1 MICROTECHNOLOGY: INTRODUCTION
1.1 History
1.2 Technologies
1.2.1 Silicon chip technology
1.2.2 Application of microtechnologies
1.3 Market value and growth
1.3.1 Bringing technologies to market
1.3.1.1 Independent investors
1.3.1.2 Governmental investment
1.4 Factors influencing the microtechnology markets
1.4.1 Cost
1.4.1.1 Medical conditions
1.4.1.2 Competition
1.4.2 Reimbursement and regulations
1.4.2.1 Acceptance

CHAPTER 2 MICROTECHNOLOGY: APPLICATIONS
2.1 Materials
2.2 Implants
2.2.1 Continence care
2.2.2 Hearing aids
2.2.3 Neurostimulation
2.2.4 Other implants
2.3 Tissue engineering
2.4 Drug delivery
2.4.1 Mechanical devices
2.4.2 Materials
2.5 Diagnostics
2.5.1 Artificial nose
2.5.2 Lab-on-a-chip
2.5.3 DNA Microarrays
2.5.3.1 DNA chips
2.5.3.2 Genosensors
2.5.4 Point of care diagnosis
2.5.5 Imaging
2.6 Cardiology
2.6.1 Catheters
2.6.2 Defibrillators
2.6.3 Pacemakers
2.6.4 Coronary stents
2.7 Pharmaceuticals
2.8 Disposable products

CHAPTER 3 MICROTECHNOLOGY: PRODUCTS
3.1 Implants
3.1.1 Continence care
3.1.2 Hearing devices
3.1.3 Neurostimulation
3.1.3.1 Limb implants
3.1.3.2 Other implants
3.2 Tissue engineering
3.3 Drug delivery
3.4 Diagnostics
3.4.1 Lab-on-a-chip
3.4.2 DNA Microarrays
3.4.3 Diagnostic machines
3.5 Cardiology
3.5.1 Defibrillators
3.5.2 Coronary stents
3.5.3 Catheters
3.5.4 Pacemakers
3.6 Pharmaceuticals
3.7 Disposable products

CHAPTER 4 NANOTECHNOLOGY
4.1 Developments in nanotechnology
4.2 Nanotechnology materials
4.2.1 Materials
4.2.1.1 Carbon nanotubes
4.2.1.2 Silicon
4.2.1.3 Ceramics
4.2.1.4 Polymers (plastics)
4.2.1.5 Biomolecules
4.3 Investment and market status
4.3.1 US funding
4.3.2 Japanese funding
4.3.3 European funding
4.4 Future prospects

CHAPTER 5 COMPANIES INVOLVED IN MICRO- AND NANOTECHNOLOGY
5.1 Advanced Bionics Corporation
5.1.1 Products
5.1.2 Company finances
5.1.3 Research and development
5.2 Applied Digital Solutions Inc
5.2.1 Products
5.2.2 Company finances
5.2.2.1 Fiscal period
5.2.2.2 Overview
5.2.3 Research and development
5.3 Aradigm Corporation
5.3.1 Products
5.3.2 Company finances
5.3.2.1 Fiscal period
5.3.2.2 Overview
5.3.3 Research and development
5.4 Caliper Technologies Corporation
5.4.1 Products
5.4.2 Company finances
5.4.2.1 Fiscal period
5.4.2.2 Overview
5.4.3 Research and development
5.5 Cochlear Limited
5.5.1 Products
5.5.2 Company finances
5.5.2.1 Fiscal period
5.5.2.2 Overview
5.5.3 Research and development
5.6 Given Imaging Ltd
5.6.1 Products
5.6.2 Company finances
5.6.2.1 Overview
5.6.3 Research and development
5.7 Interpore Cross International
5.7.1 Products
5.7.2 Company finances
5.7.2.1 Fiscal period
5.7.2.2 Overview
5.7.3 Research and development
5.8 i-STAT Corporation
5.8.1 Products
5.8.2 Company finances
5.8.2.1 Fiscal period
5.8.2.2 Overview
5.8.3 Research and development
5.9 Medtronic Inc
5.9.1 Products
5.9.2 Company finances
5.9.2.1 Fiscal period
5.9.2.2 Overview
5.9.3 Research and development
5.10 MiniMed Inc
5.10.1 Products
5.10.2 Company finances
5.10.2.1 Fiscal period
5.10.2.2 Overview
5.10.3 Research and development

REFERENCES
APPENDIX
EXCHANGE RATES